Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
986.6 INR | -0.33% | +0.11% | +21.53% |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.53% | 2.12B | |
+31.56% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.83% | 239B | |
+10.16% | 210B | |
-7.28% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- NATCOPHARM Stock
- News NATCO Pharma Limited
- US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India